Neuroprotection and Reduced Proliferation of Microglia in Ribavirin-Treated Bornavirus-Infected Rats

ABSTRACT In a rat model of Borna disease, intracerebral ribavirin caused clinical improvement without changes in virus titer or nucleic acid. Levels of microglia and infiltrating CD4 and CD8 cells were decreased, despite increases in mRNAs encoding interleukin-1β (IL-1β), IL-10, and gamma interferon in the brain. Intracerebral ribavirin may reduce morbidity through effects on microglia cell proliferation.

[1]  J. Arnold,et al.  The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.

[2]  A. Kleinschmidt,et al.  Word recognition memory before and after successful treatment of depression. , 2000, Pharmacopsychiatry.

[3]  M. Berg,et al.  Borna Disease in a Free-Ranging Lynx (Lynx lynx) , 2000, Journal of Clinical Microbiology.

[4]  T. Briese,et al.  Inhibition of Borna Disease Virus Replication by Ribavirin , 1999, Journal of Virology.

[5]  A. Berghöfer,et al.  Amantadine Revisited: An Open Trial of Amantadinesulfate Treatment in Chronically Depressed Patients with Borna Disease Virus Infection , 1999, Pharmacopsychiatry.

[6]  U. Phan,et al.  Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. , 1999, Journal of hepatology.

[7]  W. Lipkin,et al.  Effect of Immune Priming on Borna Disease , 1999, Journal of Virology.

[8]  O. Weiland,et al.  The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. , 1998, The Journal of general virology.

[9]  F. Ehrensperger,et al.  Borna Disease in a Dog with Lethal Meningoencephalitis , 1998, Journal of Clinical Microbiology.

[10]  Ming Liu,et al.  Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. , 1998, Journal of immunology.

[11]  L. Stitz,et al.  Lack of antiviral effect of amantadine in Borna disease virus infection , 1998, Medical Microbiology and Immunology.

[12]  T. Mizutani,et al.  Inhibition of Borna disease virus replication by ribavirin in persistently infected cells , 1998, Archives of Virology.

[13]  G. Davis,et al.  Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial , 1997, Hepatology.

[14]  P. Staeheli,et al.  Borna disease virus is not sensitive to amantadine , 1997, Archives of Virology.

[15]  B. Cubitt,et al.  Amantadine does not have antiviral activity against Borna disease virus , 1997, Archives of Virology.

[16]  D. Dietrich,et al.  Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression , 1997, The Lancet.

[17]  K. Ikuta,et al.  Borna disease virus RNA in peripheral blood mononuclear cells obtained from healthy dairy cattle , 1996, Medical Microbiology and Immunology.

[18]  T. Mosmann,et al.  Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection. , 1996, Journal of immunology.

[19]  H. Simmonds,et al.  Importance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans , 1995, The Journal of Biological Chemistry.

[20]  S. Kliche,et al.  Enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus-specific proteins , 1995, Journal of clinical microbiology.

[21]  J. Fallon,et al.  Behavioral disturbances and pharmacology of Borna disease. , 1995, Current topics in microbiology and immunology.

[22]  G. Koob,et al.  Tardive dyskinetic syndrome in rats infected with Borna disease virus , 1994, Neurobiology of Disease.

[23]  H. Ludwig,et al.  Borna virus infections in cattle associated with fatal neurological disease , 1994, Veterinary Record.

[24]  L. Stitz,et al.  Borna disease in naturally infected cattle. , 1994, Journal of comparative pathology.

[25]  M. Brearley.  Unusual neoplasm in a dog , 1993, Veterinary Record.

[26]  M. Malkinson,et al.  Borna disease in ostriches , 1993, Veterinary Record.

[27]  D. Morton.  Is unnecessary suffering avoidable? , 1993, The Veterinary Record.

[28]  H. Ludwig,et al.  Natural Borna disease in domestic animals others than horses and sheep. , 1993, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.

[29]  J. Prieto,et al.  Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. , 1993, Journal of hepatology.

[30]  J. Patterson,et al.  Mechanism of La Crosse virus inhibition by ribavirin , 1989, Antimicrobial Agents and Chemotherapy.

[31]  K. O'connell,et al.  Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription , 1988, Antimicrobial Agents and Chemotherapy.

[32]  G. Gosztonyi,et al.  Borna disease: a persistent virus infection of the central nervous system. , 1988, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[33]  O. Narayan,et al.  Pathogenesis of Borna disease in rats: evidence that intra-axonal spread is the major route for virus dissemination and the determinant for disease incubation , 1987, Journal of virology.

[34]  V. Knight,et al.  Biochemistry and clinical applications of ribavirin , 1986, Antimicrobial Agents and Chemotherapy.

[35]  D. Mason,et al.  Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. , 1986, Immunology.

[36]  A. Barclay,et al.  Purification, chain separation and sequence of the MRC OX‐8 antigen, a marker of rat cytotoxic T lymphocytes. , 1985, The EMBO journal.

[37]  V. Knight,et al.  Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. , 1985, Antiviral research.

[38]  G. Pauli,et al.  Focus-immunoassay for Borna disease virus-specific antigens. , 2010, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.

[39]  M. Kagnoff,et al.  Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin , 1983, Antimicrobial Agents and Chemotherapy.

[40]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[41]  L. Stitz,et al.  Borna disease in rhesus monkeys as a model for uveo‐cerebral symptoms , 1981, Journal of medical virology.

[42]  R. Smith,et al.  The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. , 1979, Biochemical and biophysical research communications.

[43]  C. Milstein,et al.  T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody , 1978, The Journal of experimental medicine.

[44]  F. Ehrensperger,et al.  [Natural borna virus infection in rabbits]. , 1978, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.

[45]  L. Philipson,et al.  Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate , 1977, Antimicrobial Agents and Chemotherapy.

[46]  R. J. Bauer,et al.  Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Kullback.  Information Theory and Statistics , 1959 .